Silvana Tesei

Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease

R Zanettini, Angelo Antonini, Gemma Gatto et al. · New England Journal of Medicine · 2007 · 884 citations · Full text

Medicine, Neurology, Cardiovascular Pharmacotherapy +1

Survival and dementia in <scp> <i>GBA</i> </scp> ‐associated Parkinson's disease: <scp>T</scp> he mutation matters

Roberto Cilia, Sara Tùnesi, Giorgio Marotta et al. · Annals of Neurology · 2016 · 409 citations

Life Sciences, Neurology, Neuroscience +17

The G6055A (G2019S) mutation in <i>LRRK2</i> is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor

Stefano Goldwurm, Alessio Di Fonzo, Erik Simons et al. · Journal of Medical Genetics · 2005 · 195 citations · Full text

Life Sciences, Genetics, Neurology +16

123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy

Angelo Antonini, Riccardo Benti, R. De Notaris et al. · Neurological Sciences · 2003 · 144 citations

Life Sciences, Neurology, Neuroscience +17

Evaluation of <i>LRRK2</i> G2019S penetrance

Stefano Goldwurm, Michele Zini, Luigi Mariani et al. · Neurology · 2007 · 140 citations

Life Sciences, Neurology, Neuroscience +12